Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 8, 1998, Pages 814-817

  Fukutake, Masato ^a   Yokota, Shigeru ^b   Kawamura, Hideki ^a   Iizuka, Akira ^a   Amagaya, Sakae ^a   Fukuda, Kazunori ^a   Komatsu, Yasuhiro ^a  

^a TSUMURA AND CO   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Aberrant crypt loci (ACF); Baicalin; Berberine; Coptidis Rhizoma; Inhibitor; Scutellariae Radix

Indexed keywords

AZOXYMETHANE; BAICALEIN; BAICALIN; BERBERINE; COPTIS RHIZOME; PROSTAGLANDIN SYNTHASE; SCUTELLARIAE RADIX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; COLON ULCER; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME INHIBITION; MALE; NEOPLASM; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; RAT;

EID: 0031752958     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.814     Document Type: Article

References (44)

1. Thun M. J., Calle E. E., Namboodiri M. M., Dana Flanders W., Coates R. J., Bycrs T., Bolfetta P., Garfinkel L., Heath C. W., Jr., J. Natl. Cancer Inst., 84, 1491-1500 (1992).
2. Ames B. N., Gold L. S., Willett W. C., Prac. Natl. Acad. Sci. U.S.A., 92, 5258-5265 (1995).
3. Alabaster O., Tang Z. C., Frost A., Shivapurkar N., Carcinojgcnesis, 16, 127-132 (1995).
4. Wattenberg L. W., Cancer Res., 52, 2085s-2091s (1992).
5. Stavric B., Clin. Biochem., 27, 319-332 (1994).
6. Ip C., Lisk D. J., Scimeca J. A., Cancer Res., 54, 1957s-1959s (1994).
7. Greenwald R. Kelloff G. J., Boone C. W., McDonald S. S., Cancer Epidemiology, Biomarkers & Prevention, 4, 691-702 (1995).
8. Takahashi M., Minamoto T., Yamashita N., Kato T., Yazawa K., Esumi H., Cancer Lett.. 83, 177-184 (1994).
9. Takahashi M., Minamoto T., Yamashita N., Yazawa K., Sugimura T., Esumi H., Cancer Res., 53, 2786-2789 (1993).
10. Reddy B. S., Sugie S., Cancer Res., 48, 6642-6647 (1988).
11. Weisburger J. H., Braley J., Reinhardt J., Aliaga C., Rivenson A., Hard G. C., Zhang X.-M., Takahashi M., Esumi H., Sugimura, T., Environ. Health Perspect., 102 (suppl 6), 53-55 (1994).
12. Reddy B. S., Sugic S., Maruyama H., EL-Bayoumy K., Marra P., Cancer Res., 47, 5901-5904 (1987).
13. Reddy B. S., Nayini J., Tokumo K., Rigotty J., Zang E., Kelloff G., Cancer Res., 50, 2562-2568 (1990).
14. Reddy B. S. Tokumo K., Kulkarni N., Aligia C., Kelloff G., Carcinogenesis, 13, 1019-1023 (1992).
15. Reddy B. S., Maruyama H., Kelloff G., Cancer Res., 47, 5340-5346 (1987).
16. Labayle D., Fischer D., Vielh P., Drouhin F., Pariente A., Bories C., Duhamel O., Trousset M., Attali P., Gastroenterology, 101, 635-639 (1991).
17. Thun M., Namboordiri M., Heath C., N. Engl J. Med., 325, 1593-1596 (1991).
18. Labayle D., Boyer J., Drouhin F., Zarka Y., Fischer F., Lancet, 343, 417-418 (1994).
19. Rao C. V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V., Reddy B. S., Cancer Res., 55, 1464-1472 (1995).
20. Narisawa T., Sato M., Tani M., Kudo T., Takahashi T., Goto A., Cancer Res., 41, 1954-1957 (1981).
21. Trujillo M. A., Garewal H. S., Sampliner R. E., Digestive Diseases and Sciences., 39, 2260-2266 (1994).
22. Okita K., Li Q., Murakami T., Takahashi M., Eur. J. Cancer Prevention, 2, 169-176 (1993).
23. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S,. Kojiro M., Cancer Res., 54, 448-454 (1994).
24. Pereira M. A., Barnes L. H., Rassman V. L., Kelloff G. V., Steele V. E., Carcinogenesis, 15, 1049-1054 (1994).
25. Bird R. P., Cancer Lett., 37, 147-151 (1987).
26. Ozaki Y., Biol. Pharm. Bull., 18, 559-562 (1995).
27. Sharma S., Stutzman J. D., Kelloff G. J., Steele V. E., Cancer Res., 54, 5848-5855 (1994).
28. Chan K., Trends Pharmacol. Sci., 16, 182-187 (1995).
29. Reddy B. S., Rao C. V., Carcinogenesis, 14, 1493-1497 (1993).
30. Swabb E. A., Tai Y.-H., Jordan L., Am. J. Physiol., 241, G248-G252 (1981).
31. Snack R. B., Froehlieh J. L., Infect. Immun., 35, 471-475 (1982).
32. Tai Y.-H., Feser J. F., Marnane W. G., Desjeux J.-F., Am. J., Physiol., 241, G253-G258 (1981).
33. Zhu B., Ahrens F. A., Eur. J. Pharmacol. 96, 11-19 (1983).
34. Zhu B., Ahrens F. A., Am. J. Vet. Res., 43, 1594-1598 (1982).
35. Fujimura H., Sawada T., Goto M., Yakitgaku Zasshi, 90, 782-783 (1970).
36. Creasey W. A., Biochem. Pharmacol., 28, 1081-1084 (1979).
37. Amin A. H., Subbaiah T. V., Abbashi K. M., Can. J. Microbiol., 15, 1067-1076 (1969).
38. Bhakuni D. S., Jain S., "The Alkaloids," Vol.28, ed. by Brossi A., Academic Press, Orlando, 1986, pp. 95-181.
39. Hhan F. E., Ciak J., "Antibiotics" Vol. 3, ed. by Corcoran J, W., Hahn F. F., Springer-Verlag, New York. 1975, pp. 577-584.
40. Ghosh A. K., Bhattacharyya F. K., Ghosh D. K., Exp. Parasitol., 60, 404-413 (1985).
41. Suffness M., Cordell G. A., "The Alkaloids." Vol. 25. ed. by Brossi A., Academic Press, Orlando, 1985, pp. 191-193.
42. Chen K.-T., Mao D.-M., Liu Z.-X., Chen Y.-C., You Z.-S., Chin. Med. J., 107, 808-812 (1994).
43. Kuo C. L., Chou C. C., Young B. Y.-M., Cancer Lett., 93, 193-200 (1995).
44. Nakatsugi S., Fukutake M., Takahashi M., Fukuda K., Isoi T., Taniguchi Y., Sugimura T., Wakabayashi K., Jpn. J. Cancer Res., 88, 1117-1120 (1997).